Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Genoscience Pharma to present novel cancer therapeutic strategy at EORTC-NCI-AACR Symposium

Genoscience Pharma to present novel cancer therapeutic strategy at EORTC-NCI-AACR Symposium

Research!America to recognize distinguished research advocates with Advocacy Awards

Research!America to recognize distinguished research advocates with Advocacy Awards

Abbvie announces multiple study results of veliparib investigational compound in NSCLC patients

Abbvie announces multiple study results of veliparib investigational compound in NSCLC patients

Spring Mountain Capital leads financing round for Oncoceutics with additional private investors' participation

Spring Mountain Capital leads financing round for Oncoceutics with additional private investors' participation

Aptose joins Beat AML research collaboration

Aptose joins Beat AML research collaboration

Daiichi Sankyo, Ambit Biosciences enter into definitive merger agreement

Daiichi Sankyo, Ambit Biosciences enter into definitive merger agreement

MIT researchers use disarmed version of anthrax toxin to deliver cancer drugs

MIT researchers use disarmed version of anthrax toxin to deliver cancer drugs

Scientists discover new clues about drug used in treating blood cancer

Scientists discover new clues about drug used in treating blood cancer

BRD4 protein appears to play key role in keeping stem cells in immature "pluripotent" state

BRD4 protein appears to play key role in keeping stem cells in immature "pluripotent" state

Novel treatment makes life-saving difference to young patients with Ph-like ALL

Novel treatment makes life-saving difference to young patients with Ph-like ALL

Eutropics inks NCI contract to develop Praedicare Dx platform technology for AML treatments

Eutropics inks NCI contract to develop Praedicare Dx platform technology for AML treatments

Scientists identify gene mutation that causes aplastic anemia

Scientists identify gene mutation that causes aplastic anemia

Amgen seeks FDA approval for leukemia drug blinatumomab

Amgen seeks FDA approval for leukemia drug blinatumomab

Researchers discover new molecule that allows for multiplication of stem cells in cord blood

Researchers discover new molecule that allows for multiplication of stem cells in cord blood

Dominica Anderson named recipient of 2014 Julie and Ben Rogers Award for Excellence in Patient Care

Dominica Anderson named recipient of 2014 Julie and Ben Rogers Award for Excellence in Patient Care

UCSD researchers launch phase 1 trial to assess novel monoclonal antibody for CLL patients

UCSD researchers launch phase 1 trial to assess novel monoclonal antibody for CLL patients

3SBio signs exclusive license agreement with JenKem for PEG-irinotecan

3SBio signs exclusive license agreement with JenKem for PEG-irinotecan

Complete analysis of the global stem cell market

Complete analysis of the global stem cell market

Blocking bacteria's access to iron: an interview with Dr. Laxminarayana Devireddy

Blocking bacteria's access to iron: an interview with Dr. Laxminarayana Devireddy

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.